Correlation Between Vigil Neuroscience and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Vigil Neuroscience and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Apellis Pharmaceuticals.
Diversification Opportunities for Vigil Neuroscience and Apellis Pharmaceuticals
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Vigil and Apellis is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vigil Neuroscience and Apellis Pharmaceuticals
Given the investment horizon of 90 days Vigil Neuroscience is expected to generate 1.04 times more return on investment than Apellis Pharmaceuticals. However, Vigil Neuroscience is 1.04 times more volatile than Apellis Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 166.00 in Vigil Neuroscience on October 20, 2024 and sell it today you would earn a total of 27.00 from holding Vigil Neuroscience or generate 16.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vigil Neuroscience vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Vigil Neuroscience |
| Apellis Pharmaceuticals |
Vigil Neuroscience and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vigil Neuroscience and Apellis Pharmaceuticals
The main advantage of trading using opposite Vigil Neuroscience and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Vigil Neuroscience vs. Molecular Partners AG | Vigil Neuroscience vs. Pmv Pharmaceuticals | Vigil Neuroscience vs. Monte Rosa Therapeutics | Vigil Neuroscience vs. Entrada Therapeutics |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |